Skip to content
value.today

Biothera Holding Corp.

🇺🇸 Eagan, Minnesota, USABiotechnologyFounded 2013
Total raised
$16 M
2 rounds on record
Latest round
$15 M
Apr 2017
First round on record
Oct 2014
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Biothera Holding Corp.
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2017$15 MNo. 2$10 to $50 million

Biothera Holding Corp.: Raise no. 2, Apr 2017

Investors in this round

139 investors had bought by the notice of Mar 15, 2018: 139 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $25 M offered; $10 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, other: Class A Common Stock and Warrants to Purchase Class A Common Stock
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Minnesota

People named in the notice

  • Richard L. Mueller · Executive Officer, Director
  • Steven L. Karel · Executive Officer, Director
  • William L. Gacki · Executive Officer
  • Alex L. Giaquinto · Director
  • Andrew L. LaFrence · Director
  • Dick L. Pfister · Director
  • Dwight L. Porter · Director
  • Robert L. Hill · Director
  • Steve L. King · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Executive officer is not compensated for sales of securities that are offered by the Company.”

Signed by William L. Gacki, Chief Financial Officer. Source: SEC Form D and 1 amendment, newest notice filed Mar 15, 2018. Read the notice at the SEC.

equity, optionsSEC
Oct 2014$2 MNo. 1Under $2 million

Biothera Holding Corp.: Raise no. 1, Oct 2014

Investors in this round

28 investors had bought by the notice of Dec 10, 2014: 28 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $57 M offered; $55 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt, other: Exchange Offer of 10% Senior Subordinated Convertible notes and private placement of new notes or Common Stock
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
$100,000
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks finders' fees as estimates
The company
Corporation, incorporated in Minnesota

People named in the notice

  • Daniel L. Conners · Executive Officer, Director
  • Richard L. Mueller · Executive Officer, Director
  • Steven L. Karel · Executive Officer, Director
  • William L. Gacki · Executive Officer
  • Alex L.A. Giaquinto · Director
  • Andrew L.A. LaFrence · Director
  • Annalisa L.A. Jenkins · Director
  • Bruce L.A. Carter · Director
  • Dick L.A. Pfister · Director
  • Dwight L.A. Porter · Director
  • Robert L.A. Hill · Director
  • Steve L.A. King · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Ron King · Miromar Lakes, FloridaSold in FL, MN
  • Kevin Elder · Minneapolis, MinnesotaSold in MN, WI

Remarks in the notice

  • On the amounts: “$50 million Exchange Offer of 10% Senior Subordinated Convertible notes and private placement of $7 million new notes or Common Stock”

Signed by William L. Gacki, Chief Financial Officer. Source: SEC Form D, newest notice filed Dec 10, 2014. Read the notice at the SEC.

equity, debtSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Biothera Holding Corp. chose not to state its revenue in its newest notice of a funding round (Mar 2018).

    SEC Form D · Mar 2018

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Mar 2018

That is all the official record says: Biothera Holding Corp. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Biothera Holding Corp. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 139 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Biothera Holding Corp.
NameRoleNamed in
Richard L. MuellerExecutive officerMar 2018
Steven L. KarelExecutive officerMar 2018
William L. GackiExecutive officerMar 2018
Daniel L. ConnersExecutive officerDec 2014
Alex L. GiaquintoDirectorMar 2018
Andrew L. LaFrenceDirectorMar 2018
Dick L. PfisterDirectorMar 2018
Dwight L. PorterDirectorMar 2018
Richard L. MuellerDirectorMar 2018
Robert L. HillDirectorMar 2018
Steve L. KingDirectorMar 2018
Steven L. KarelDirectorMar 2018
Annalisa L. JenkinsDirectorMay 2017
Alex L.A. GiaquintoDirectorDec 2014
Andrew L.A. LaFrenceDirectorDec 2014
Annalisa L.A. JenkinsDirectorDec 2014
Bruce L.A. CarterDirectorDec 2014
Daniel L. ConnersDirectorDec 2014
Dick L.A. PfisterDirectorDec 2014
Dwight L.A. PorterDirectorDec 2014
Robert L.A. HillDirectorDec 2014
Steve L.A. KingDirectorDec 2014